Replies to post #171598 on Kraig Biocraft Laboratories Inc (KBLB)

[DimesForShares]

Reverse split is a nasty card to play

Thompson won't be holding on to an Ace if he plays the reverse split last. It's more like a Joker. Depending on how investors view this, it could be okay or it could be a bad thing.

Uplisting without solid news of corporate partnerships, production, and sales will not solve KBLB's problems. Only partnerships, production, and sales will move the company forward.

[igotthemojo]

"It’s a mistake not to understand that it is ALL about the uplist."

I think its a mistake to not understand, a r/s HAS to happen before the up list can...

after that, its just a matter of choosing the best time to do it...

it is not a card to be played...it is not a good thing to hold onto for the right moment...

it is a bad thing that has to happen...and the idea is to minimize the damage...

[EOT]

Just keep in mind that we have had ZERO production news.

If this M designer has a product line then we obviously have mass production and when word gets out we certainly won’t need an rs.

Proven Spider silk mass production capabilities will take care of the price.